OXFORD, England, October 30, 2025--(BUSINESS WIRE)--ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE ® SL Self-Loading MHC Class I ...
Partnership will validate high quality, species-specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseases OXFORD, England & ...
Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscape Speakers include thought leaders in biotherapeutics, complex ...
OXFORD, England, November 18 ProImmune Ltd, a leadingprovider of quality research reagents for monitoring the immune system andepitope discovery, has today announced the introduction of the ...
ProImmune, a leader in services for understanding immune responses, today announced the introduction of MutaMapâ„¢, a new high-throughput assay service for understanding the impact of point mutations on ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
ProImmune, life sciences reagents and services provider, has announced the opening on its new global headquarters building at Oasis Park, following its recent acquisition of the site. Oasis Park, ...
OXFORD, England & EDINBURGH, Scotland--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin ...
Partnership will validate high quality, species-specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseases ProImmune Ltd, a global ...
ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh's Roslin Institute to advance veterinary immunology research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results